IL117670A - Low dose ridogrel formulations for treatment of inflammatory bowel diseases - Google Patents
Low dose ridogrel formulations for treatment of inflammatory bowel diseasesInfo
- Publication number
- IL117670A IL117670A IL11767096A IL11767096A IL117670A IL 117670 A IL117670 A IL 117670A IL 11767096 A IL11767096 A IL 11767096A IL 11767096 A IL11767096 A IL 11767096A IL 117670 A IL117670 A IL 117670A
- Authority
- IL
- Israel
- Prior art keywords
- ridogrel
- formulations
- treatment
- inflammatory bowel
- low dose
- Prior art date
Links
- 208000022559 Inflammatory bowel disease Diseases 0.000 title 1
- 238000009472 formulation Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- GLLPUTYLZIKEGF-HAVVHWLPSA-N ridogrel Chemical compound C=1C=CC(C(F)(F)F)=CC=1C(=N/OCCCCC(=O)O)\C1=CC=CN=C1 GLLPUTYLZIKEGF-HAVVHWLPSA-N 0.000 title 1
- 229950006674 ridogrel Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4406—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 3, e.g. zimeldine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP95200768 | 1995-03-28 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL117670A0 IL117670A0 (en) | 1996-07-23 |
| IL117670A true IL117670A (en) | 2000-02-29 |
Family
ID=8220134
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL11767096A IL117670A (en) | 1995-03-28 | 1996-03-27 | Low dose ridogrel formulations for treatment of inflammatory bowel diseases |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP0817631A2 (de) |
| JP (1) | JPH10511097A (de) |
| AR (1) | AR002727A1 (de) |
| AU (1) | AU5397496A (de) |
| CA (1) | CA2215160A1 (de) |
| HU (1) | HUP9900309A3 (de) |
| IL (1) | IL117670A (de) |
| NO (1) | NO974486L (de) |
| WO (1) | WO1996030016A2 (de) |
| ZA (1) | ZA962461B (de) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9620709D0 (en) * | 1996-10-04 | 1996-11-20 | Danbiosyst Uk | Colonic delivery of weak acid drugs |
| EP1370244A1 (de) * | 2001-03-12 | 2003-12-17 | Novo Nordisk A/S | Neue tabletten und kapseln und verfahren zu ihrer herstellung |
| ITRM20050389A1 (it) | 2005-07-22 | 2007-01-23 | Giuliani Spa | Composti e loro sali specifici per i recettori ppar ed i recettori per l'egf e loro uso in campo medico. |
| UA107562C2 (uk) | 2008-12-05 | 2015-01-26 | Спосіб лікування псоріазу | |
| WO2010091894A2 (en) | 2009-02-16 | 2010-08-19 | Giuliani International Limited | Methods of treating hair related conditions |
| CN109999017A (zh) | 2012-02-09 | 2019-07-12 | 诺格拉制药有限公司 | 治疗纤维化的方法 |
| CN104284655B (zh) | 2012-04-18 | 2017-10-27 | 诺格拉制药有限公司 | 治疗乳糖不耐受的方法 |
| WO2017046343A1 (en) * | 2015-09-17 | 2017-03-23 | Nogra Pharma Limited | Compositions for rectal administration in the treatment of ulcerative colitis and methods of using same |
| EP4495101A3 (de) | 2019-02-08 | 2025-04-30 | Nogra Pharma Limited | Verfahren zur herstellung von 3-(4'-aminophenyl)-2-methoxypropionsaure, sowie analoge uno zwischenprodukte davon |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4746671A (en) * | 1985-11-04 | 1988-05-24 | Janssen Pharmaceutica N.V. | Pharmaceutical use of [[[(3-pyridinyl)methylen]amino]oxy]alkanoic acids and esters |
-
1996
- 1996-03-18 AU AU53974/96A patent/AU5397496A/en not_active Abandoned
- 1996-03-18 WO PCT/EP1996/001229 patent/WO1996030016A2/en not_active Ceased
- 1996-03-18 EP EP96910921A patent/EP0817631A2/de not_active Withdrawn
- 1996-03-18 CA CA002215160A patent/CA2215160A1/en not_active Abandoned
- 1996-03-18 JP JP8528894A patent/JPH10511097A/ja active Pending
- 1996-03-18 HU HU9900309A patent/HUP9900309A3/hu unknown
- 1996-03-27 IL IL11767096A patent/IL117670A/xx active IP Right Grant
- 1996-03-27 AR ARP960101944A patent/AR002727A1/es unknown
- 1996-03-27 ZA ZA9602461A patent/ZA962461B/xx unknown
-
1997
- 1997-09-29 NO NO974486A patent/NO974486L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO974486D0 (no) | 1997-09-29 |
| CA2215160A1 (en) | 1996-10-03 |
| JPH10511097A (ja) | 1998-10-27 |
| WO1996030016A3 (en) | 1997-01-30 |
| ZA962461B (en) | 1997-09-29 |
| IL117670A0 (en) | 1996-07-23 |
| EP0817631A2 (de) | 1998-01-14 |
| MX9707394A (es) | 1997-11-29 |
| HUP9900309A3 (en) | 1999-11-29 |
| AU5397496A (en) | 1996-10-16 |
| WO1996030016A2 (en) | 1996-10-03 |
| HUP9900309A2 (hu) | 1999-05-28 |
| AR002727A1 (es) | 1998-04-29 |
| NO974486L (no) | 1997-09-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SI0730864T1 (en) | Medicament for treating cardiac inflammatory diseases | |
| IL161833A0 (en) | Pharmaceutical compositions and usethereof for thetreatment of psychotic diseases | |
| HUP9903489A3 (en) | Use of epinastine for the preparation of pharmaceutical compositions treating pain | |
| HUP9900950A3 (en) | Use of nicotine derivatives for producing pharmaceutical compositions suitable for treating inflammatory bowel disease | |
| EP0759750A4 (de) | Präparate zur behandlung von chronischen entzündlichen erkrankungen | |
| AU2027595A (en) | Pharmaceutical composition for treating inflammatory bowel diseases | |
| AU6590896A (en) | Pharmaceutical compositions containing tsg-6 for treating inflammatory diseases and cancer-related pathologies and methods | |
| HUP0001084A3 (en) | Modified release oral pharmaceutical composition containing 5-asa for the treatment of bowel diseases | |
| HUP9904317A3 (en) | Use of 1-hydroxy-2-pyridones for producing pharmaceutical compositions suitable for the treatment of skin diseases | |
| HUP9900147A2 (hu) | Terápiás szerek és autoimmun betegségek kezelésére alkalmas gyógyszerkészítmények | |
| AU6858996A (en) | Pharmaceutical compositions for the treatment of infectious diseases | |
| GR3035622T3 (en) | Azo derivatives of 5-aminosalicylic acid for treatment of inflammatory bowel disease | |
| IL117670A (en) | Low dose ridogrel formulations for treatment of inflammatory bowel diseases | |
| AU2886292A (en) | Compositions and methods for treatment of epstein-barr virus-associated diseases | |
| HUP9901247A3 (en) | Use of naphthimidazole-, naphthoxazole- and naphthothiazole-diones for the preparation of pharmaceutical compositions treating diseases caused by vascular function deficiency | |
| HU9204028D0 (en) | Medical preparative for treatment of diseases of mamma | |
| GB2300807B (en) | Oral dosage forms of omega-3 polynunsaturated acids for the treatment of inflammatory bowel disease | |
| HUP9801925A3 (en) | Use of sodium-hydrogen-exchange-inhibitors for producing pharmaceutical compositions treating diseases caused by protozoons | |
| ZA95908B (en) | A synergistic formulation for treatment of rheumatic diseases | |
| HK1008178A (en) | Low dose ridogrel formulations and their use for the treatment of inflammatory bowel diseases | |
| HUP9702408A3 (en) | Use of 5-phenyloxazolidin-2-one derivatives for the preparation of pharmaceutical compositions treating diseases requiring tumour necrosis factor (tnf) inhibition | |
| ZA944671B (en) | Medicaments for the treatment of inflammatory diseases | |
| EP0796105A4 (de) | Pharmazeutische zusammensetzung zur behandlung von autoimmun krankheiten mit dem b-oligomer des pertussis toxin oder untereinheiten davon | |
| IL114923A0 (en) | Chintin extract for treatment of skin disease | |
| ZA968902B (en) | Methods and compositions for treatment of diseases |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted |